METROPOLITAN LIFE INSURANCE CO/NY - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$13,191
-39.1%
4,2010.0%0.00%0.0%
Q2 2023$21,677
-2.1%
4,2010.0%0.00%0.0%
Q1 2023$22,139
+68.9%
4,201
-10.0%
0.00%0.0%
Q4 2022$13,111
-32.3%
4,6660.0%0.00%0.0%
Q3 2022$19,364
+98.8%
4,666
+92.6%
0.00%
Q2 2022$9,740
-61.0%
2,423
-52.0%
0.00%
-100.0%
Q1 2022$24,988
-80.8%
5,048
-73.0%
0.00%
-50.0%
Q4 2021$130,367
-34.8%
18,704
-6.5%
0.00%
-33.3%
Q3 2021$200,040
-29.5%
20,0040.0%0.00%
-25.0%
Q2 2021$283,657
-3.8%
20,004
+11.3%
0.00%0.0%
Q1 2021$295,003
-24.2%
17,977
-4.4%
0.00%
-33.3%
Q4 2020$389,181
+172.0%
18,8010.0%0.01%
+100.0%
Q3 2020$143,076
+12.6%
18,801
+23.3%
0.00%
+50.0%
Q2 2020$127,033
+72.9%
15,250
+2.7%
0.00%0.0%
Q1 2020$73,468
-99.9%
14,842
+21.1%
0.00%
+100.0%
Q2 2018$82,749,000
+51943.4%
12,259
-28.5%
0.00%0.0%
Q2 2017$159,000
+14.4%
17,157
+73.5%
0.00%0.0%
Q3 2015$139,000
-33.2%
9,8870.0%0.00%0.0%
Q2 2015$208,0009,8870.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 5,618,424$46,801,000100.00%
Opaleye Management Inc. 5,984,200$49,848,00010.07%
DELTEC ASSET MANAGEMENT LLC 2,330,267$19,411,0004.06%
Corriente Advisors, LLC 720,000$5,998,0003.89%
Versant Venture Management, LLC 2,215,384$18,454,145,0002.65%
SV Health Investors, LLC 312,068$2,600,0001.80%
Ikarian Capital, LLC 2,055,977$17,126,0001.36%
EAM Global Investors LLC 265,316$2,210,0000.99%
EAM Investors, LLC 346,075$2,883,0000.64%
RA Capital Management 2,727,272$22,718,0000.44%
View complete list of OCULAR THERAPEUTIX INC shareholders